Catalyst Pharmaceuticals Inc banner

Catalyst Pharmaceuticals Inc
NASDAQ:CPRX

Watchlist Manager
Catalyst Pharmaceuticals Inc Logo
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Watchlist
Price: 24.17 USD -0.41%
Market Cap: $3B

Wall Street
Price Targets

CPRX Price Targets Summary
Catalyst Pharmaceuticals Inc

Wall Street analysts forecast CPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPRX is 35.19 USD with a low forecast of 32.32 USD and a high forecast of 42 USD.

Lowest
Price Target
32.32 USD
34% Upside
Average
Price Target
35.19 USD
46% Upside
Highest
Price Target
42 USD
74% Upside
Catalyst Pharmaceuticals Inc Competitors:
Price Targets
HOTH
Hoth Therapeutics Inc
443% Upside
RYI
Ryerson Holding Corp
-14% Downside
IBEX
Ibex Ltd
39% Upside
ZNTL
Zentalis Pharmaceuticals Inc
104% Upside

Revenue
Forecast

N/A
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate of Catalyst Pharmaceuticals Inc's revenue for the next 4 years is 11%.

Operating Income
Forecast

N/A
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

The compound annual growth rate of Catalyst Pharmaceuticals Inc's operating income for the next 4 years is 14%.

Net Income
Forecast

N/A
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
N/A
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

The compound annual growth rate of Catalyst Pharmaceuticals Inc's net income for the next 4 years is 29%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CPRX's stock price target?
Price Target
35.19 USD

According to Wall Street analysts, the average 1-year price target for CPRX is 35.19 USD with a low forecast of 32.32 USD and a high forecast of 42 USD.

What is Catalyst Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
11%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's revenue for the next 4 years is 11%.

What is Catalyst Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
14%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's operating income for the next 4 years is 14%.

What is Catalyst Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
29%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's net income for the next 4 years is 29%.

Back to Top